About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 2NCT01318889

Dexpanthenol Mouthwash to Treat Oral Mucositis

Oral mucositis can be a significant problem for cancer patients. It is typically associated with pain and increased risk of infection and can lead to impaired nutritional status and inadequate hydrati...

Lead sponsor: Shahid Beheshti University of Medical Sciences•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Fahimeh Anbari, resident

CONTACT

+98 9197263620 fahimeh.anbari@gmail.com

Jamileh beigom Taheri, professor

CONTACT

jm_taheri2006@yhoo.com

Sponsors

Lead Sponsor

Shahid Beheshti University of Medical Sciences

Patients will be given a bottle of 5% Dexpanthenol mouthwash and they are asked to rinse 10 ml of it three times a day. At the onset of mucositis and then for 4 subsequent weeks they will be examined to evaluate the condition of their oral mucosa.By the advent of mucositis stage 4 ,at any time during the 4 weeks of study,the patient would be out.if any patient shows allergic reaction to dexpanthenol,he/she would be out of study too.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. without any systemic disease
•2. estimated survival of at least 6 months
•3. without any mental disorders
•4. grade 1 to 3 WHO mucositis

Exclusion Criteria

•1. development of grade 4 WHO mucositis
•2. Brachytherapy
•3. allergy to the drug
•4. dissatisfaction of the patient

Related studies

WITHDRAWNPhase 2

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

NCT06708702 · Oral Mucositis, Oral Mucositis (Ulcerative) Due to Radiation, and more

Not Yet RecruitingPhase 2

Aerosolized Mesenchymal Stem Cell-Derived Exosomes for the Prevention and Treatment of Radiation-Induced Oral Mucositis

NCT07312656 · Oral Mucositis (Ulcerative) Due to Radiation

COMPLETEDPhase 3

A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis

NCT07186114 · Oral Mucositis (Ulcerative) Due to Radiation

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

NCT03972527 · Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, and more

COMPLETEDPhase 2

Melatonin for Prevention of Radiation Induced Oral Mucositis

NCT03833570 · Oral Mucositis (Ulcerative) Due to Radiation

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 6, 2011Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment30

Start dateSep 2010

Last updatedJul 6, 2011

Condition

Oral Mucositis (Ulcerative) Due to Radiation

Locations shown

ShaheedBeheshti medical university

Tehran

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2011Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions